XTL Biopharmaceuticals to acquire Psyga Bio for 40% stake
Corroborated by 2 sources from 2 publishers
globalhealth1d ago
TL;DR
Reports differ across sources; according to investing.com, xTL Biopharmaceuticals to acquire Psyga Bio for 40% stake.
Corroborated by 2 sources from 2 publishers
Reports differ across sources; according to investing.com, xTL Biopharmaceuticals to acquire Psyga Bio for 40% stake.